跳至主要内容
临床试验/NCT00929721
NCT00929721已完成不适用

Global Active Surveillance for Community-Acquired Pneumonia (CAP) in Adults 50 Years and Older

Pfizer2 个研究点 分布在 1 个国家目标入组 5,172 人开始时间: 2009年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Pfizer
入组人数
5,172
试验地点
2
主要终点
Incidence rates of CAP in adults 50 years and older

研究概览

简要总结

This study is an observational surveillance study to identify adults 50 years and older who present to a study healthcare facility with signs and symptoms of Community-Acquired Pneumonia.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
盲法
None

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult subjects 50 years of age or older
  • Subject must reside in the surveillance area
  • Subjects who present to a study healthcare facility where the treating physician clinically suspects CAP

排除标准

  • Any subject who is transferred to a study healthcare facility after already being hospitalized for 48 hours or more at any other in-patient facility (such as a community hospital).
  • Hospital Acquired pneumonia (ie, develops signs and symptoms of pneumonia after being hospitalized for 48 hours or more).

结局指标

主要结局

Incidence rates of CAP in adults 50 years and older

时间窗: up to 120 days from enrollment

次要结局

  • Frequency of bacterial agents associated with CAP, Case fatality and incidence rates of CAP number and characteristics of subjects from outpatient clinics, emergency rooms, and hospital in-patient departments(up to 120 days from enrollment)

研究者

发起方
Pfizer
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验